Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis

Journal of Rheumatology

Volumn 37, Issue 12, 2010, Pages 2548-2552

  Hanke, Katharina ^a   Becker, Mike O ^a   Brueckner, Claudia S ^a   Meyer, Wolfgang ^b   Janssen, Anthonina ^b   Schlumberger, Wolfgang ^b   Hiepe, Falk ^a   Burmester, Gerd R ^a   Riemekasten, Gabriela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Anticentromere antibodies; Systemic sclerosis

Indexed keywords

CENTROMERE A ANTIBODY; CENTROMERE ANTIBODY; CENTROMERE B ANTIBODY; CENTROMERE PROTEIN A; CENTROMERE PROTEIN B; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIFFUSE SCLERODERMA; DIGITAL ULCER; DISEASE ASSOCIATION; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; IMMUNOASSAY; JOINT CONTRACTURE; KIDNEY DISEASE; LINE IMMUNOBLOT ASSAY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SCLERODERMA; SCLERODERMA OVERLAP SYNDROME; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCER; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE;

ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; CENTROMERE PROTEIN B; CHROMOSOMAL PROTEINS, NON-HISTONE; HUMANS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 78649742724     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100402     Document Type: Article

References (18)

1. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980;77:1627-31. (Pubitemid 10073815)
2. He D, Zeng C, Woods K, Zhong L, Turner D, Busch RK. CENP-G: a new centromeric protein that is associated with the alpha-1 satellite DNA subfamily. Chromosoma 1998;107:189-97.
3. Rattner JB, Rao A, Fritzler MJ, Valencia DW, Yen TJ. CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motil Cytoskeleton 1993;26:214-26.
4. Rattner JB, Rees J, Arnett FC, Reveille JD, Goldstein R, Fritzler MJ. The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. Arthritis Rheum 1996;39:1355-61.
5. Saito A, Muro Y, Sugiura K, Ikeno M, Yoda K, Tomita Y. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis. J Rheumatol 2009;36:781-6.
6. Akbarali Y, Matousek-Ronck J, Hunt L, Staudt L, Reichlin M, Guthridge JM, et al. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun 2006;27:272-80.
7. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005;32:1488-94.
8. Walker JG, Fritzler MJ. Update on autoantibodies in systemic sclerosis. Curr Opin Rheumatol 2007;19:580-91.
9. Reveille JD, Solomon DH, and The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003;49:399-412.
10. Russo K, Hoch S, Dima C, Varga J, Teodorescu M. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol 2000;27:142-8.
11. Mahler M, Maes L, Blockmans D. Clinical and serological evaluation of a novel CENP-A peptide based ELISA. Arthritis Res Ther 2010;12:R99.
12. Hanke K, Dahnrich C, Bruckner CS, Huscher D, Becker M, Jansen A, et al. Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Arthritis Res Ther 2009;11:R28.
13. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology 2008;47:1185-92.
14. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis 2007;66:754-63.
15. Hanke K, Bruckner CS, Dahnrich C, Huscher D, Komorowski L, Meyer W, et al. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 2009;11:R22.
16. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998;25:84-8.
17. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
18. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999;42:899-909.